Association Between Different Domains of Physical Activity and Body Adiposity Indicators in Breast Cancer Survivors [0.03%]
乳腺癌幸存者不同身体活动类型与体型肥胖指标的关系研究
Daniela Tanajura Caldeira Silva,Luiz Carlos Marques Vanderlei,Mariana Romanholi Palma et al.
Daniela Tanajura Caldeira Silva et al.
Background: To analyze the relationship between different physical activity (PA) domains and adiposity indicators in breast cancer survivors. Methods: ...
Current Status and Problems of Breast Cancer Treatment with Schizophrenia [0.03%]
乳腺癌合并精神分裂症的治疗现状及问题
Kazuhisa Kaneshiro,Makoto Kubo,Masahiko Taniguchi et al.
Kazuhisa Kaneshiro et al.
Background: Schizophrenia is a devastating mental disease that affects approximately 1% of the world's population. Breast cancer is the second most common type of cancer in the world that causes death in women. It is ofte...
The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC [0.03%]
在HR阳性/HER2阴性MBC患者的不断演变的治疗格局中化疗的地位
Chris Twelves,Rupert Bartsch,Noa Efrat Ben-Baruch et al.
Chris Twelves et al.
Endocrine therapy (ET) for the treatment of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR-positive/HER2-negative) metastatic breast cancer (MBC) has changed markedly over recent years with the...
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC) [0.03%]
奥特龙尼尔在雄激素受体表达的转移性乳腺癌患者中的一项二期研究评估，奥特龙尼尔是一种雄激素生物合成抑制剂。
注：为了使翻译更加通顺和符合中文阅读习惯，我稍微调整了语序，但保留了原文的主要信息。如果需要完全直译，请告知。
Denise A Yardley,Robyn R Young,Kerin B Adelson et al.
Denise A Yardley et al.
Background: AR is a targetable pathway with AR modulation inhibiting estrogen- and androgen-mediated cell proliferation. Orteronel is an oral, selective, nonsteroidal inhibitor of 17, 20-lyase, a key enzyme in androgen bi...
Clinical Trial
Clinical breast cancer. 2022 Apr;22(3):269-278. DOI:10.1016/j.clbc.2021.10.011 2022
Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions? [0.03%]
超声弹性成像有助于更好地管理乳腺BI - RADS 4类病变？
Yang Gu,Jiawei Tian,Haitao Ran et al.
Yang Gu et al.
Background: To assess the performance of conventional ultrasound (US) combined with strain elastography (SE) in the Breast Imaging Reporting and Data System (BI-RADS) category 4 lesions on mammography. ...
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al [0.03%]
乳腺/胸壁和区域淋巴结的低分割放射治疗（HFRT）在局部晚期乳腺癌中的毒性特征和生存结果：回顾性单机构研究：关于De Matteis等人的研究
Yasemin Bölükbasi,Ezgi Oymak,Duygu Sezen et al.
Yasemin Bölükbasi et al.
Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy [0.03%]
放射治疗乳腺癌患者中与辐射性皮炎相关的症状负担
Lauren Milton,Tara Behroozian,Nim Li et al.
Lauren Milton et al.
Purpose: Radiation dermatitis (RD) is a side effect experienced by many patients undergoing radiotherapy (RT) for breast cancer. In the present study, the Edmonton Symptom Assessment System (ESAS), a validated patient-rep...
YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer [0.03%]
YY1诱导的FAM111B转录激活促进乳腺癌恶性进展
Wei Li,Sihui Hu,Zhiqiang Han et al.
Wei Li et al.
Background: Family with sequence similarity 111 member B (FAM111B) is an oncoprotein associated with multiple malignancies. We investigated the potential mechanisms of FAM111B in breast cancer. ...
Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy [0.03%]
使用对比增强分光哺乳摄影预测导管内原位癌的低估诊断结果
Hee Jung Shin,Woo Jung Choi,Seo Young Park et al.
Hee Jung Shin et al.
Background: To assess the performance of contrast-enhanced spectral mammography (CESM) for the prediction of DCIS underestimation in comparison with mammography, breast US, and breast MRI. ...
The Effect of Supplemental Imaging on Interval Cancer Rates in Mammography Screening: Systematic Review [0.03%]
补充影像对乳腺X线筛查间隔癌症率影响的系统评价
Aileen Zeng,Meagan E Brennan,Sharon Young et al.
Aileen Zeng et al.
Supplemental screening with MRI or ultrasound increases cancer detection rate (CDR) in women with standard screening mammography. Whether it also reduces interval cancer rate (ICR) is unclear. This study reviewed the evidence evaluating the...